BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18951979)

  • 1. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.
    Balakumar P; Sharma R; Singh M
    Pharmacol Res; 2008; 58(5-6):356-63. PubMed ID: 18951979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Verma S; Reddy K; Balakumar P
    Biol Trace Elem Res; 2010 Oct; 137(1):96-109. PubMed ID: 19943121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
    Kaur J; Reddy K; Balakumar P
    Cardiovasc Toxicol; 2010 Sep; 10(3):227-38. PubMed ID: 20694523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Kaur T; Goel RK; Balakumar P
    Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
    Chakkarwar VA
    Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
    Jindal S; Singh M; Balakumar P
    Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARĪ³-eNOS-NO signals.
    Taneja G; Mahadevan N; Balakumar P
    Cardiovasc Toxicol; 2013 Jun; 13(2):110-22. PubMed ID: 23208382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of PPARĪ³-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
    Kathuria S; Mahadevan N; Balakumar P
    Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
    Shah DI; Singh M
    Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.
    Balakumar P; Chakkarwar VA; Singh M
    Mol Cell Biochem; 2009 Jan; 320(1-2):149-62. PubMed ID: 18830571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction.
    Shah DI; Singh M
    Int J Cardiol; 2007 Sep; 120(3):317-24. PubMed ID: 17240464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.
    Jyoti U; Kansal SK; Kumar P; Goyal S
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):167-75. PubMed ID: 26497187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
    Bhardwaj P; Khanna D; Balakumar P
    Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats.
    Shah DI; Singh M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):595-604. PubMed ID: 17109653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of protein kinase A improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Endothelium; 2006; 13(4):267-77. PubMed ID: 16990183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
    Nirwane A; Pawar V; Majumdar A
    J Complement Integr Med; 2015 Jun; 12(2):143-51. PubMed ID: 25870973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of agmatine on experimental vascular endothelial dysfunction.
    Nader MA; Gamiel NM; El-Kashef H; Zaghloul MS
    Hum Exp Toxicol; 2016 May; 35(5):573-82. PubMed ID: 26424770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorative effect of daidzein: a caveolin-1 inhibitor in vascular endothelium dysfunction induced by ovariectomy.
    Sharma S; Singh M; Sharma PL
    Indian J Exp Biol; 2012 Jan; 50(1):28-34. PubMed ID: 22279937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.